We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Indiana Oncologist Over Failure to Follow Trial Procedures
FDA Warns Indiana Oncologist Over Failure to Follow Trial Procedures
June 9, 2014
Indianapolis oncologist Ruemu Birhiray was hit with an FDA warning letter after investigators uncovered multiple procedural failures at his clinical trial site.